Associated Papers
Analysis of CRISPR-Cas9 screens identifies genetic dependencies in melanoma.
Christodoulou E et al.
Pigment Cell & Melanoma Research, 2021
32767816 (PubMed )
Supplement: PCMR-34-122-s006.xlsx › Sheet1
Analyzing aggregation propensities of clinically relevant PTEN mutants: a new culprit in pathogenesis of cancer and other PTENopathies.
Palumbo E et al.
Journal of Biomolecular Structure & Dynamics, 2020
31232187 (PubMed )
Supplement: supplement_1.zip › Supplement_S4_mutants_nochange.xlsx › Mutants_no_change
EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer.
Oldrini B et al.
Nature Communications, 2017
29229958 (PubMed )
Supplement: 41467_2017_2185_MOESM8_ESM.xlsx › Table_S7
Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours.
Wong SQ et al.
Scientific Reports, 2013
Genetic alterations of PTEN in human melanoma.
Aguissa-Touré AH et al.
Cellular and Molecular Life Sciences : Cmls, 2012
Osteopontin is a downstream effector of the PI3-kinase pathway in melanomas that is inversely correlated with functional PTEN.
Packer L et al.
Carcinogenesis, 2006
PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines.
Pollock PM et al.
Melanoma Research, 2002
Select a paper to view details